bisoprolol has been researched along with cardiovascular agents in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 3 (15.00) | 29.6817 |
| 2010's | 11 (55.00) | 24.3611 |
| 2020's | 5 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meyer, C | 1 |
| Chen, J; Christopher, TA; Gao, F; Gu, J; Lopez, BL; Lysko, P; Ma, XL; Ohlstein, EH; Ruffolo, RR; Yue, TL | 1 |
| Lechat, P; Médiani, O; Mougenot, N | 1 |
| Adcock, IM; Anker, SD; Bolger, AP; Dietz, R; Genth-Zotz, S; Kalra, PR; Kemp, M; Poole-Wilson, PA; von Haehling, S | 1 |
| González Oliva, JC; Pou Potau, M; Ramírez de Arellano Serna, M; Salas Gama, KR; Saurina i Solé, A | 1 |
| Alonso, RM; Ferreirós, N; Gonzalez, O; Iriarte, G; Jiménez, RM; Maguregui, MI; Rico, E | 1 |
| Garganeeva, AA; Shabanova, MV | 1 |
| Charles, H; Cochrane, L; Elder, DH; Lang, CC; Mohan, M | 1 |
| Bocchi, EA; Böhm, M; Borer, JS; Ford, I; Komajda, M; Swedberg, K; Tavazzi, L | 1 |
| Astarita, C; Capuano, N; Cirillo, T; Coppola, A; Rigo, F; Romano, C; Tagliamonte, E | 1 |
| Knyazkova, II; Kuzminova, NV; Osovska, NY | 1 |
| Borisenko, YV; Kanorsky, SG | 1 |
| Bodén, R; Holmlöv, K; Lindström, L; Mohsen, I; Nilsson, BM | 1 |
| Brader, P; Kapl, M; Muster, V; Rainer, P; Reittner, P; Schmidt, A; Szolar, DH; Tillich, M; von Lewinski, D; von Lewinski, F; Wallner, M | 1 |
| Akiyama, T; Iwanaga, Y; Kakehi, K; Miyazaki, S; Shimizu, S; Sonobe, T; Watanabe, H; Yamamoto, H | 1 |
| Hachiya, H; Imai, Y; Kabutoya, T; Kario, K; Komori, T; Morita, E; Okuyama, T; Shimpo, M; Watanabe, H; Watanabe, T; Yokota, A | 1 |
| Ivkin, D; Karpov, A; Kaschina, E; Krasnova, M; Kulikov, A; Okovityi, S; Smirnov, A | 1 |
| Al-Lamee, R; Davies, JR; Foley, M; Francis, DP; Ganesananthan, S; Gerber, R; Howard, J; Keeble, TR; Malik, IS; Nijjer, S; Nowbar, AN; O'Kane, P; Petraco, R; Rajkumar, CA; Seligman, H; Sen, S; Sharp, ASP; Shun-Shin, M; Tang, KH | 1 |
| Calo', L; Cicogna, F; de Ruvo, E; Martino, A; Politano, A; Rebecchi, M; Sette, A; Sgueglia, M; Volterrani, M | 1 |
| Koiwa, H; Matsushima, S; Morisaki, H; Morisaki, T; Naya, M; Tsujinaga, S; Yokota, T | 1 |
5 trial(s) available for bisoprolol and cardiovascular agents
| Article | Year |
|---|---|
Effect of Combining Ivabradine and β-Blockers: Focus on the Use of Carvedilol in the SHIFT Population.
Topics: Adrenergic beta-Antagonists; Aged; Benzazepines; Bisoprolol; Carbazoles; Cardiovascular Agents; Carvedilol; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure, Systolic; Hospitalization; Humans; Ivabradine; Male; Metoprolol; Middle Aged; Nebivolol; Propanolamines; Proportional Hazards Models; Treatment Outcome | 2015 |
Ivabradine and Bisoprolol on Doppler-derived Coronary Flow Velocity Reserve in Patients with Stable Coronary Artery Disease: Beyond the Heart Rate.
Topics: Aged; Benzazepines; Bisoprolol; Blood Flow Velocity; Cardiovascular Agents; Coronary Artery Disease; Double-Blind Method; Drug Monitoring; Echocardiography, Doppler; Female; Fractional Flow Reserve, Myocardial; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2015 |
[Comparative Evaluation of -blockers and If-Channel Inhibitor in Patients With Chronic Heart Failure and Preserved Left Ventricular Ejection Fraction].
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Benzazepines; Bisoprolol; Cardiovascular Agents; Exercise Tolerance; Female; Heart Failure; Heart Ventricles; Humans; Ivabradine; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Quality of Life; Stroke Volume; Ventricular Function, Left | 2016 |
Achieving Optimal Medical Therapy: Insights From the ORBITA Trial.
Topics: Amlodipine; Bisoprolol; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Fractional Flow Reserve, Myocardial; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isosorbide Dinitrate; Male; Middle Aged; Nicorandil; Percutaneous Coronary Intervention; Ranolazine; Treatment Outcome; Vasodilator Agents | 2021 |
Ivabradine versus bisoprolol in the treatment of inappropriate sinus tachycardia: a long-term follow-up study.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Bisoprolol; Cardiovascular Agents; Electrocardiography, Ambulatory; Exercise Test; Exercise Tolerance; Female; Follow-Up Studies; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Prospective Studies; Quality of Life; Surveys and Questionnaires; Tachycardia, Sinus; Treatment Outcome; Young Adult | 2021 |
15 other study(ies) available for bisoprolol and cardiovascular agents
| Article | Year |
|---|---|
New drugs in the cardiovascular arena.
Topics: Amlodipine; Bisoprolol; Cardiovascular Agents; Cardiovascular Diseases; Humans; Quinolines; Sotalol; Vasodilator Agents | 1993 |
Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Antioxidants; Bisoprolol; Carbazoles; Cardiovascular Agents; Carvedilol; Creatine Kinase; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Rate; Isoproterenol; Lipid Peroxidation; Male; Membrane Lipids; Myocardial Ischemia; Myocardium; Peroxidase; Propanolamines; Rabbits; Reperfusion Injury; Ventricular Pressure | 2000 |
Bisoprolol and hydrochlorothiazide effects on cardiovascular remodeling in spontaneously hypertensive rats.
Topics: Animals; Bisoprolol; Cardiovascular Agents; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Heart Rate; Hydrochlorothiazide; Hypertension; Male; Rats; Rats, Inbred SHR; Ventricular Remodeling | 2005 |
Effect of noradrenaline and isoproterenol on lipopolysaccharide-induced tumor necrosis factor-alpha production in whole blood from patients with chronic heart failure and the role of beta-adrenergic receptors.
Topics: Adrenergic beta-Antagonists; Adult; Bisoprolol; Cardiovascular Agents; Female; Heart Failure; Humans; Isoproterenol; Lipopolysaccharides; Male; Norepinephrine; Receptors, Adrenergic, beta; Tumor Necrosis Factor-alpha | 2005 |
[Difficult-to-treat atrial fibrillation in a patient on haemodialysis].
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Atrial Fibrillation; Bisoprolol; Bradycardia; Calcium Channel Blockers; Cardiovascular Agents; Combined Modality Therapy; Digoxin; Diltiazem; Female; Humans; Hypothyroidism; Kidney Failure, Chronic; Myocardial Infarction; Pacemaker, Artificial; Renal Dialysis | 2010 |
LC-MS/MS method for the determination of several drugs used in combined cardiovascular therapy in human plasma.
Topics: Ammonium Sulfate; Atenolol; Bisoprolol; Cardiovascular Agents; Chromatography, Liquid; Drug Stability; Formates; Humans; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2010 |
[Effect of optimal pulse slowing therapy on the course of recovery period in patients with ischemic heart disease after surgical myocardial revascularization].
Topics: Benzazepines; Bisoprolol; Cardiovascular Agents; Comparative Effectiveness Research; Drug Monitoring; Drug Therapy, Combination; Exercise Tolerance; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Myocardial Ischemia; Myocardial Revascularization; Postoperative Complications; Tachycardia; Treatment Outcome | 2014 |
Characterizing patients with chronic heart failure in community care after hospitalization: a potential role for ivabradine.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Bisoprolol; Cardiovascular Agents; Chronic Disease; Clinical Protocols; Drug Utilization; Female; Heart Failure; Hospitalization; Humans; Ivabradine; Male; Medication Therapy Management; Middle Aged; Retrospective Studies; United Kingdom | 2015 |
Loeffler endocarditis in young woman - a case report.
Topics: Adult; Benzazepines; Bisoprolol; Cardiovascular Agents; Endocardium; Female; Humans; Hypereosinophilic Syndrome; Ivabradine; Poland; Retrospective Studies; Treatment Outcome | 2016 |
Persistent tachycardia in clozapine treated patients: A 24-hour ambulatory electrocardiogram study.
Topics: Adult; Antipsychotic Agents; Bisoprolol; Cardiovascular Agents; Clozapine; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Male; Photoperiod; Tachycardia; Time Factors | 2018 |
Heart rate-reducing therapy with add-on ivabradine and bisoprolol before coronary computed tomographic angiography in a fast-track ambulatory setting.
Topics: Aged; Bisoprolol; Cardiovascular Agents; Clinical Protocols; Computed Tomography Angiography; Coronary Artery Disease; Drug Therapy, Combination; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Retrospective Studies | 2018 |
Modulation of Sympathetic Activity and Innervation With Chronic Ivabradine and β-Blocker Therapies: Analysis of Hypertensive Rats With Heart Failure.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Bisoprolol; Cardiovascular Agents; Disease Models, Animal; Heart; Heart Failure; Heart Rate; Hypertension; Ivabradine; Male; Myocardium; Norepinephrine; Parasympathetic Nervous System; Rats, Inbred Dahl; Sodium Chloride, Dietary; Sympathetic Nervous System; Tyrosine 3-Monooxygenase; Ventricular Function, Left | 2019 |
Time Course of Left Ventricular Pseudoaneurysm After Catheter Ablation of LVOT Tachycardia.
Topics: Aneurysm, False; Bisoprolol; Cardiovascular Agents; Catheter Ablation; Female; Heart Ventricles; Humans; Middle Aged; Tachycardia, Ventricular; Ventricular Dysfunction, Left | 2020 |
Comparative efficacy of empagliflozin and drugs of baseline therapy in post-infarct heart failure in normoglycemic rats.
Topics: Animals; Benzhydryl Compounds; Bisoprolol; Cardiovascular Agents; Chronic Disease; Disease Models, Animal; Exercise Tolerance; Fosinopril; Glucosides; Heart Failure; Male; Myocardial Infarction; Rats, Wistar; Sodium-Glucose Transporter 2 Inhibitors; Spironolactone; Ventricular Dysfunction, Left; Ventricular Function, Left | 2020 |
Loeys-Dietz Cardiomyopathy? Long-term Follow-up After Onset of Acute Decompensated Heart Failure.
Topics: Acute Disease; Bisoprolol; Cardiomegaly; Cardiomyopathies; Cardiovascular Agents; Echocardiography; Genetic Testing; Heart Failure; Humans; Loeys-Dietz Syndrome; Losartan; Male; Middle Aged; Mutation; Pulmonary Edema; Receptor, Transforming Growth Factor-beta Type I; Spironolactone; Treatment Outcome; Ventricular Dysfunction, Left | 2022 |